bisindolylmaleimide i has been researched along with Carcinoma, Pancreatic Ductal in 3 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thongon, N | 1 |
| Castiglioni, I | 1 |
| Zucal, C | 1 |
| Latorre, E | 1 |
| D'Agostino, V | 1 |
| Bauer, I | 1 |
| Pancher, M | 1 |
| Ballestrero, A | 1 |
| Feldmann, G | 1 |
| Nencioni, A | 1 |
| Provenzani, A | 1 |
| Ito, T | 1 |
| Kojima, T | 1 |
| Yamaguchi, H | 1 |
| Kyuno, D | 1 |
| Kimura, Y | 1 |
| Imamura, M | 1 |
| Takasawa, A | 1 |
| Murata, M | 1 |
| Tanaka, S | 1 |
| Hirata, K | 1 |
| Sawada, N | 1 |
| Tanaka, M | 1 |
| Shibahara, J | 1 |
| Fukushima, N | 1 |
| Shinozaki, A | 1 |
| Umeda, M | 1 |
| Ishikawa, S | 1 |
| Kokudo, N | 1 |
| Fukayama, M | 1 |
3 other studies available for bisindolylmaleimide i and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line | 2016 |
Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Claudins; DNA Methylation; Enzyme Activation; Gene E | 2011 |
Claudin-18 is an early-stage marker of pancreatic carcinogenesis.
Topics: Adenocarcinoma, Mucinous; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Cel | 2011 |